GCP
GNCA

GSA Capital Partners’s Genocea Biosciences, Inc. GNCA Stock Holding History

GSA Capital Partners’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-80,876
Closed -$219K – 1737
2021
Q1 		$219K Sell
80,876
-49,869
-38% -$148K 0.04% 848
2020
Q4 		$316K Buy
+130,745
New +$298K 0.05% 705
2018
Q2 		– Sell
-29,258
Closed -$246K – 2072
2018
Q1 		$246K Buy
29,258
+21,283
+267% +$177K 0.01% 1389
2017
Q4 		$74K Buy
7,975
+1,812
+29% +$18.2K ﹤0.01% 1489
2017
Q3 		$72K Buy
6,163
+3,763
+157% +$143K ﹤0.01% 1539
2017
Q2 		$100K Buy
+2,400
New +$116K 0.01% 1590

Other funds holding GNCA

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AICPI
ABG Innovation Capital Partners III Central, Hong Kong, Hong Kong $64.5K AUM 1.01% 1-Year Est. Return

GSA Capital Partners's GNCA Position: Q2 2021 in Review

GSA Capital Partners sold out of Genocea Biosciences, Inc. (GNCA) in Q2 2021, closing a stake of 80,876 shares — an estimated $219K sold.

GSA Capital Partners first reported a position in GNCA in Q2 2017 and held it in 6 quarters. The position peaked at $316K in Q4 2020. 46 funds tracked by Wall St. Rank hold GNCA as of Q2 2021.

  • GSA Capital Partners reported no remaining Genocea Biosciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • GSA Capital Partners sold 80,876 Genocea Biosciences, Inc. shares in Q2 2021, an estimated $219K.
  • GSA Capital Partners first reported a position in Genocea Biosciences, Inc. in Q2 2017 and held it in 6 quarters.
  • GSA Capital Partners's Genocea Biosciences, Inc. position peaked at $316K in Q4 2020.
  • 46 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q2 2021.

Based on GSA Capital Partners's 13F filing for Q2 2021, filed 5 Aug 2021.